ArticleJournal of advanced veterinary and animal research2025
Investigating the Devil's tree(
Article in Journal of advanced veterinary and animal research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study was formulated to analyze the health benefits and antifungal and anthelmintic properties of Alstonia scholaris, specifically its bark, as claimed in Mizo traditional medicine. Biochemical assays were set up to evaluate the antioxidant potential and bioactivity tests on activity against pathogenic fungi and helminth parasites. Materials and Methods: Alstonia scholaris bark extract was prepared in petroleum ether, a non-polar solvent. Phytochemical detections were performed for 11 chemical tests. The total antioxidant, flavonoid, and phenol contents were determined. The free radical-scavenging reactions were determined using 2,2-diphenyl-1-picrylhydrazine (DPPH) scavenging and ferric ion-reducing antioxidant power (FRAP) assays. The antifungal activity was tested by an agar diffusion method. Anthelmintic activity was assessed by survival assay, scanning electron microscopy, and histology. Results: Phytosterols were identified as the main bioactive compounds. The total antioxidant was estimated at 6.4305 mg ascorbate equivalent per gram, flavonoid at 128.03 mg gallic acid equivalent per gram, and phenol at 10.72 mg pentahydroxyflavone equivalent per gram. The FRAP assay demonstrated a concentration-dependent scavenging of ferric (Fe⁺³) cations. The DPPH scavenging reaction showed the half-maximal inhibitory concentration at 136 µg/ml. It was found that the plant extract was effective against Candida albicans, Neocosmospora keratoplastica, and Neosartorya fumigata, with the highest degree of inhibition against C. albicans. It exhibited activity against the poultry tapeworm, Raillietina echinobothrida. Light and electron microscopy revealed signature antiparasitic effects on different parts of the parasite body. Conclusion: The study vindicated the medicinal properties of A. scholaris in terms of antioxidants, antifungal, and antiparasitic activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.